For determining these heterogeneities, we designed a systematic study and meta-analysis according to the previous results, in order to achieve a more precise estimation of the correlation between the genes involved in the IGF pathway (IGF1, IGF1R, IRS1, and IRS2) and the risk of CRC for the first time. The gene discussed is IGF1R; the disease is colorectal carcinoma.